MEGLUMINE SALT FORMS OF 2-((1 R,4R)-4-(4-(5-(BENZOXAZOL-2-YLAMINO)PYRIDIN-2-YL)PHENYL)CYCLOHEXYL) ACETIC ACID AND THEIR USE AS DGAT1 INHIBITORS

MEGLUMINE SALT FORMS OF 2-((1 R,4R)-4-(4-(5-(BENZOXAZOL-2-YLAMINO)PYRIDIN-2-YL)PHENYL)CYCLOHEXYL) ACETIC ACID AND THEIR USE AS DGAT1 INHIBITORS

The present invention relates to novel crystalline forms of meglumine salts of 2-((1 R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl) phenyl)cyclohexyl)acetic acid :Formule(I) and their use in the treatment or prevention of a condition or a disorder associated with DGATl activity in animals, pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DELACRUZ MARILYN, ZHANG LIJUN, CAPACCI-DANIEL CHRISTINA, JAIN AKASH, GONG BAOQING, LU YANSONG
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DELACRUZ MARILYN
ZHANG LIJUN
CAPACCI-DANIEL CHRISTINA
JAIN AKASH
GONG BAOQING
LU YANSONG
description The present invention relates to novel crystalline forms of meglumine salts of 2-((1 R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl) phenyl)cyclohexyl)acetic acid :Formule(I) and their use in the treatment or prevention of a condition or a disorder associated with DGATl activity in animals, particularly humans.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN104995188A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN104995188A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN104995188A3</originalsourceid><addsrcrecordid>eNqNi0EKwjAURLtxIeodvrsWDFitUJdp-ms-pIkkEWw3UiSuRAW9h1c2iAcQBt7wmBkn7xZ36tCSRnBceWiMbR2YBlYsTXOwi8JmrGBpzIalFereHHlvFFuxTvH4M9m-s1ST_ppsL1FHiE4oI_EYK3CBnkQE1cB1DV4iWTg4BO6g3nGfA2lJFXlj3TQZXYbrM8x-nCTzBr2QLDzup_B8DOdwC6-T0Pmy2G43eVny9T-bD5w0Pkg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MEGLUMINE SALT FORMS OF 2-((1 R,4R)-4-(4-(5-(BENZOXAZOL-2-YLAMINO)PYRIDIN-2-YL)PHENYL)CYCLOHEXYL) ACETIC ACID AND THEIR USE AS DGAT1 INHIBITORS</title><source>esp@cenet</source><creator>DELACRUZ MARILYN ; ZHANG LIJUN ; CAPACCI-DANIEL CHRISTINA ; JAIN AKASH ; GONG BAOQING ; LU YANSONG</creator><creatorcontrib>DELACRUZ MARILYN ; ZHANG LIJUN ; CAPACCI-DANIEL CHRISTINA ; JAIN AKASH ; GONG BAOQING ; LU YANSONG</creatorcontrib><description>The present invention relates to novel crystalline forms of meglumine salts of 2-((1 R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl) phenyl)cyclohexyl)acetic acid :Formule(I) and their use in the treatment or prevention of a condition or a disorder associated with DGATl activity in animals, particularly humans.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20151021&amp;DB=EPODOC&amp;CC=CN&amp;NR=104995188A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20151021&amp;DB=EPODOC&amp;CC=CN&amp;NR=104995188A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DELACRUZ MARILYN</creatorcontrib><creatorcontrib>ZHANG LIJUN</creatorcontrib><creatorcontrib>CAPACCI-DANIEL CHRISTINA</creatorcontrib><creatorcontrib>JAIN AKASH</creatorcontrib><creatorcontrib>GONG BAOQING</creatorcontrib><creatorcontrib>LU YANSONG</creatorcontrib><title>MEGLUMINE SALT FORMS OF 2-((1 R,4R)-4-(4-(5-(BENZOXAZOL-2-YLAMINO)PYRIDIN-2-YL)PHENYL)CYCLOHEXYL) ACETIC ACID AND THEIR USE AS DGAT1 INHIBITORS</title><description>The present invention relates to novel crystalline forms of meglumine salts of 2-((1 R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl) phenyl)cyclohexyl)acetic acid :Formule(I) and their use in the treatment or prevention of a condition or a disorder associated with DGATl activity in animals, particularly humans.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi0EKwjAURLtxIeodvrsWDFitUJdp-ms-pIkkEWw3UiSuRAW9h1c2iAcQBt7wmBkn7xZ36tCSRnBceWiMbR2YBlYsTXOwi8JmrGBpzIalFereHHlvFFuxTvH4M9m-s1ST_ppsL1FHiE4oI_EYK3CBnkQE1cB1DV4iWTg4BO6g3nGfA2lJFXlj3TQZXYbrM8x-nCTzBr2QLDzup_B8DOdwC6-T0Pmy2G43eVny9T-bD5w0Pkg</recordid><startdate>20151021</startdate><enddate>20151021</enddate><creator>DELACRUZ MARILYN</creator><creator>ZHANG LIJUN</creator><creator>CAPACCI-DANIEL CHRISTINA</creator><creator>JAIN AKASH</creator><creator>GONG BAOQING</creator><creator>LU YANSONG</creator><scope>EVB</scope></search><sort><creationdate>20151021</creationdate><title>MEGLUMINE SALT FORMS OF 2-((1 R,4R)-4-(4-(5-(BENZOXAZOL-2-YLAMINO)PYRIDIN-2-YL)PHENYL)CYCLOHEXYL) ACETIC ACID AND THEIR USE AS DGAT1 INHIBITORS</title><author>DELACRUZ MARILYN ; ZHANG LIJUN ; CAPACCI-DANIEL CHRISTINA ; JAIN AKASH ; GONG BAOQING ; LU YANSONG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN104995188A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DELACRUZ MARILYN</creatorcontrib><creatorcontrib>ZHANG LIJUN</creatorcontrib><creatorcontrib>CAPACCI-DANIEL CHRISTINA</creatorcontrib><creatorcontrib>JAIN AKASH</creatorcontrib><creatorcontrib>GONG BAOQING</creatorcontrib><creatorcontrib>LU YANSONG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DELACRUZ MARILYN</au><au>ZHANG LIJUN</au><au>CAPACCI-DANIEL CHRISTINA</au><au>JAIN AKASH</au><au>GONG BAOQING</au><au>LU YANSONG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MEGLUMINE SALT FORMS OF 2-((1 R,4R)-4-(4-(5-(BENZOXAZOL-2-YLAMINO)PYRIDIN-2-YL)PHENYL)CYCLOHEXYL) ACETIC ACID AND THEIR USE AS DGAT1 INHIBITORS</title><date>2015-10-21</date><risdate>2015</risdate><abstract>The present invention relates to novel crystalline forms of meglumine salts of 2-((1 R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl) phenyl)cyclohexyl)acetic acid :Formule(I) and their use in the treatment or prevention of a condition or a disorder associated with DGATl activity in animals, particularly humans.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_CN104995188A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title MEGLUMINE SALT FORMS OF 2-((1 R,4R)-4-(4-(5-(BENZOXAZOL-2-YLAMINO)PYRIDIN-2-YL)PHENYL)CYCLOHEXYL) ACETIC ACID AND THEIR USE AS DGAT1 INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A56%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DELACRUZ%20MARILYN&rft.date=2015-10-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN104995188A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true